Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8527
Reference
MSAN(2025)40
Name
Estradiol (Progynova® TS) 50micrograms/24hours and 100micrograms/24hours transdermal patches
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Health Boards
Pharmaceutical Services
Supplies
Drug Shortages
Description
Progynova® TS 50micrograms/24hours and 100micrograms/24hours transdermal patches (once weekly estradiol patches) will be discontinued from late December 2025 and February 2026, respectively.
FemSeven® 50micrograms/24 hours and 100micrograms/24 hours transdermal patches (once-weekly estradiol patches) remain available and can support the increase in demand.
Evorel® 50micrograms and 100micrograms and Estraderm® MX 50micrograms and 100micrograms transdermal patches (twice-weekly estradiol patches) remain available and can support the increase in demand.
Contact Name
Contact Email
Contact Address
Created
2025-08-19 08:20:00
Click to go back to homepage